Retrograde Technique: High Success Rate in CTO

Original Title: Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry.

Reference: Dimitri Karmpaliotis et al. Circ Cardiovasc Interv. 2016 Jun;9(6).

 

Retrograde Technique CTOThis study evaluated the safety and efficacy of the retrograde technique for chronic total occlusions. Researchers compared retrograde vs. anterograde technique outcomes in 1,301 procedures from 11 experienced centers across the US between the years 2012 and 2015.

Population mean age was 65.5±10 years with high diabetes prevalence (45%) and prior MI revascularization surgery (34%).

Globally, technical success was 90%, which reflects the experience of these centers, and major cardiovascular adverse events rate was 2.4%.

The retrograde technique was used in 539 cases (41%), both as initial strategy (46%) and after a failed anterograde attempt (54%).

Comparing both techniques, the retrograde technique was used in more complex cases, both from the clinical (prior surgery 48% vs. 24%; p<0.001) and angiographic point of views (mean Japan CTO score 3.1±1.0 vs 2.1±1.2; p<0.001) and resulted in lower technical success (85% vs. 94%; p<0.001) and higher complications rate (4.3% vs 1.1%; p<0.001).

Multivariable analyzis showed that the presence of suitable collaterals, no prior CABG and the left anterior descending artery as target vessel were success predictors for the retrograde technique.

Conclusion

The retrograde approach is commonly used in the daily contemporary practice especially on most challenging lesions and patients. Despite lower success and higher complications rates compared to the anterograde technique, it is an essential tool to maintain high success rates in chronic total occlusions.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...